Fu Yu Corporation (F13) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
29 Oct, 2026Executive summary
Continuing-operations revenue rose 10.4% YoY to S$60.452m, while net loss from continuing operations widened to S$9.805m.
Manufacturing revenue growth followed the cessation of supply chain services in Q4 FY2024; that segment had contributed $72.0m revenue in H1 2024.
Eight new manufacturing contracts worth S$23.2m were secured, with revenue recognition expected from 2H25 as mass production begins.
Financial highlights
Gross profit was S$6.845m, down 2.8% YoY; adjusted EBITDA excluding forex and one-off costs was S$2.337m versus S$2.957m.
Continuing-operations loss reflected S$3.0m of Zhuhai closure costs, S$3.2m of forex losses and one-off professional fees.
Selling and administrative expenses rose 29.2% to $11.9m, including $2.2m of additional professional fees and a $553k bad-debt write-off.
Other operating expenses were $6.1m versus $0.9m of income in H1 2024, including a $2.9m FX loss and $3.0m Zhuhai closure provision.
Loss per share was 1.28 cents versus 0.05 cents in H1 2024.
Outlook and guidance
New project revenue is expected from 2H25 as mass production begins; long-term cost savings from the Zhuhai wind-down are expected from 2H2025.
Priorities include growing the project pipeline, business development, cost reduction and margin improvement; professional fees are expected to decline from 2H25.
Operational strategies and financial instruments are intended to mitigate future forex losses.
Latest events from Fu Yu Corporation
- Revenue fell 58% as weaker demand drove a quarterly loss; transformation targets biomedical growth.F13
Q1 2023 TU - Weaker demand drove a 1H23 loss as investment targeted higher-value growth.F13
H1 2023 - 9M23 revenue fell 34.0% and the period swung to a S$5.8 million net loss.F13
Q3 2023 TU - Smart Factory and biomedical expansion anchor the shift to higher-precision growth.F13
Corporate presentation - FY2023 loss amid weaker demand; recovery and transformation support FY2024 improvement.F13
H2 2023 - Revenue more than doubled, but manufacturing weakness limited net profit to S$5,200.F13
Q1 2024 TU - Revenue rose 78.0%, returning 1H2024 to profit as supply chain services led growth.F13
H1 2024 - 9M2024 revenue surged 55.2% as operating results returned to profit.F13
Q3 2024 TU - Core manufacturing grew, but one-off costs, FX losses and audit qualifications cloud recovery.F13
H2 2025